MLchartDataset catalogue

Gallium Ga 68 NNS309

Term · Oncology and biomedicine · MLC-T-ONC-013829

A radioconjugate composed of NNS309, which targets an as of yet unelucidated target on tumor cells, that is conjugated to the radionuclide gallium (Ga) 68, with potential use in diagnostic imaging using positron emission tomography/computed tomography (PET/CT). Upon administration of gallium Ga 68 NNS309, the NNS309 moiety targets and binds to tumor cells expressing the target. This allows the assessment of binding of NNS309 to tumor cells and the possible therapeutic response to NNS309 conjugated to a radionuclide delivering cytotoxic radiation, such as lutetium Lu 177 (Lu177).

Table 1. Record
IdentifierMLC-T-ONC-013829
FieldOncology and biomedicine
Synonyms68Ga-NNS309; [68Ga]-NNS309
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013829",
  "term": "Gallium Ga 68 NNS309",
  "field": "Oncology and biomedicine",
  "definition": "A radioconjugate composed of NNS309, which targets an as of yet unelucidated target on tumor cells, that is conjugated to the radionuclide gallium (Ga) 68, with potential use in diagnostic imaging using positron emission tomography/computed tomography (PET/CT). Upon administration of gallium Ga 68 NNS309, the NNS309 moiety targets and binds to tumor cells expressing the target. This allows the assessment of binding of NNS309 to tumor cells and the possible therapeutic response to NNS309 conjugated to a radionuclide delivering cytotoxic radiation, such as lutetium Lu 177 (Lu177).",
  "synonyms": [
    "68Ga-NNS309",
    "[68Ga]-NNS309"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/gallium-ga-68-nns309/"
}

Record 7,708 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.